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Abstract 
Phagocytosis of blood cells by malignant plasma cells in multiple myeloma is an extremely rare condition. Here 
we present a 39-year-old woman with multiple myeloma. Bone marrow smear showed an extensive phagocytosis of 
erythrocytes and platelets by myeloma cells. 
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1. Introduction 
Several reports have been published concern- 
ing the phenomenon of phagocytic plasma cells 
[l-11]. In the majority of cases the patients had 
myelomatosis or a “monoclonal gammopathy of 
undetermined significance”. Phagocytosis is mor- 
phologically very characteristic but remains a rare 
phenomenon. 
Here, we describe a 39-year-old woman of 
Hindu origin, with Stage IIIA multiple myeloma 
and evident cytological signs of extensive phago- 
cytosis of erythrocytes, platelets and occasionally 
polynuclear granulocytes and normoblasts by ma- 
lignant plasma cells. We were able to character- 
ize phagocytosis throughout the disease. 
* Corresponding author. 
2. Case report 
The patient consulted the Ear, Nose and 
Throat CENT) department with pain in the throat. 
These symptoms resolved following treatment 
with antibiotics. In 1 month she had lost 5 kg 
body weight. Medical history and physical exami- 
nation were otherwise unremarkable. 
Laboratory results: erythrocyte sedimentation 
rate (ESR) 138 mm (after 1 h); haemoglobin 6.3 
mmol/l; MCV 95 fl; platelets 139 X 109/1; white 
blood cell count 3.7 x 109/1; normal peripheral 
blood differential; bilirubin, liver enzymes, creati- 
nine and urea normal; calcium 2.41 mmoI/l; al- 
bumin 34 g/l and protein 108 g/l; serum immu- 
noelectrophoresis revealed an IgC-A paraprotein. 
Quantitative immunoglobulin determinations 
showed IgG 70.7 g/l, IgA 0.25 g/l, and IgM 0.29 
g/l. Urinary electrophoresis demonstrated free 
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A-chains. Cytological examination of the bone 
marrow aspirate demonstrated 40% plasma cells, 
some with an atypical morphology. Considerable 
numbers of the plasma cells showed abundant 
vacuolization and phagocytosis of erythrocytes, 
platelets and occasionally polynuclear granulo- 
cytes and normoblasts (Figs. 1 and 2). Bone mar- 
row biopsy showed numerous atypical plasma cells 
and fibrosis. Cytoplasmic immunofluorescence 
demonstrated that 99% of the plasma cells in the 
bone marrow were IgG-A-positive. The phago- 
cytic plasma cells showed non-fluorescent vac- 
uoles confirming that these vacuoles did not con- 
tain immunoglobulins (Figs. 3 and 4). 
There were no indications of haemolytic 
Fig. 2. Phagocytosis of a granular leukocyte, a normoblast and 
possibly a lymphocyte by a myeloma cell. 
Fig. 1. Erythrophagocytosis by a plasma cell with two nuclei. 
anaemia or diffuse intravascular coagulation as 
described in previous studies [lO,ll]. The phago- 
cytic cells were negative for TdT. Cytochemical 
investigation showed neither esterase nor peroxi- 
dase activity. The IgG synthesis rate was 12.6 
pg/plasma cell/24 h and was linear during this 
culture period. The immunoglobulin synthesis 
rate in myeloma cells in our laboratory varied 
between 5.0 and 50.0 pg/plasma cell/24 h. The 
DNA index was 3.0 (normal range 2.8-3.5). 
X-ray skeletal survey revealed lytic spots in the 
left third rib and sternum, and radionuclide bone 
scan demonstrated high activity at these sites. 
The diagnosis multiple myeloma Stage IIIA 1121 
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was made based on clinical observations [12] as 
well as by measurement of the tumor mass (2.1 x 
lOI myeloma cells) [13]. Therapy was started 
with prednisone and melphalan. The presence of 
phagocytizing plasma cells in the bone marrow 
was confirmed at subsequent occasions when the 
patient was followed up. 
Cytogenetics: Bone marow aspirate was ob- 
tained 3 months after the start of therapy and 
cultured for l-4 days according to standard pro- 
cedures: 63 metaphases were karyotyped using R- 
and Q-banding techniques. The metaphases ob- 
tained after 1, 2, and 3 days of culture were 
mainly of myeloid origin, showing a normal kary- 
otype (n = 47). The majority of cells karyotyped 
after 4 days in culture were abnormal pseu- 
dodiploid (n = 12) or hypotetraploid (12 = 4) with 
a modal chromosome number of 85 and similar 
markers as in the pseudodiploid clone. The fol- 
lowing aberrations were seen in all 16 abnormal 
cells: du(lXq12q44), -13, del(15Xq24 or 25). 16q-, 
+ 21. Additional structural changes were present 
in some cells: del(lXp21p32X3 x ), t(lq::3p) (5 x 1, 
de1(13Xq14?) (3 x ), 14q+ (4 x ), 2Oq- (4 x ), 
+22(3 X ) as well as incidental non-clonal breaks 
and re-arrangements. 
Figs. 3 and 4. Phagosomes in IgG- and A-positive plasma cells. 
28 P.M. Vanhagen et al. /Netherlands Journal of Medicine 46 (1995) 25-29 
3. Discussion 
Granulocytes, monocytes, macrophages and 
cells from the reticula-endothelial system nor- 
mally express the ability of phagocytosis. Plasma 
cells, the producers of the immunoglobulins, nor- 
mally do not express phagocytic functions. How- 
ever, a few reports have indicated that on rare 
occasions normal B-lymphocytes may possess the 
capacity to incorporate latex particles, red blood 
cells and micro-organisms [14-X]. Hairy cells 
have been reported to have selective phagocytic 
capability with respect to latex particles and zy- 
mosan [17,18]. In vitro phagocytosis has also, al- 
though highly infrequently, been described in 
leukaemic cells of B-chronic lymphocytic 
leukaemia and B-lymphocytic leukaemia [ 19,201. 
Myeloma cells have been shown to internalize 
horseradish peroxidase (HRP), a marker of 
fluid-phase endocytosis, and cationized ferritin 
(CF), a tracer of absorptive endocytosis, after 
incubation in vitro [21]. HRP products were ob- 
served in the lysosomes and CF on the cell sur- 
face, rough endoplasmatic reticulum and in the 
Golgi complex. These observations suggest that 
fluid phase endocytosis and membrane traffic may 
occur in myeloma cells [21]. Nevertheless, in vivo, 
phagocytic activity in human lymphoproliferative 
disorders has only been found in exceptional 
cases. Reports concerned with phagocytic plasma 
cells have nearly always been in association with 
multiple myeloma [l-11,21]. The age and sex 
distribution of patients with multiple myeloma 
that is characterized by phagocytic plasma cells 
appear to be comparable with multiple myeloma 
in general. The proportion of myeloma cells in 
peripheral blood slides exceeded 5% in 5 of 17 
patients. The immunoglobulin class and type of 
M-component have no distinct characteristics [5]. 
Phagocytosis of erythrocytes, normoblasts, 
polynuclear granulocytes and even a few cases of 
phagocytosis of lymphocytes have been reported. 
Apparently, in most cases a high percentage of 
the plasma cells were vacuolated, suggesting the 
formation of phagosomes. The percentage of 
phagocytic cells in myeloma cells described in the 
literature has varied between 0.2 and 36% [5]. 
The pathogenesis of phagocytosis by myeloma 
cells remains unresolved. Possible explanations, 
e.g. the relationship between the phagocytic phe- 
nomenon and the malignant transformation of 
these cells, still lack experimental evidence. 
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